Indications and Purposes
| 1 Indications And Usage Isentress® Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Patients 4 Weeks Of Age And Older. The Use Of Other Active Agents With Isentress Is Associated With A Greater Likelihood Of Treatment Response [See Clinical Studies (14)]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Raltegravir Potassium |
|
ZINC13831130 |